Continued Access to Pain Management and Opioids: Balancing Risks and Benefits (CO*RE REMS Activity)
The course curriculum is fully compliant with the FDA’s September 2018 FDA Blueprint for Opioid Analgesic REMS Education and the 2022 Centers for Disease Control and Prevention (CDC) Clinical Practice Guideline for Prescribing Opioids for Pain. This session also meets many states’ requirements for controlled substances CE. 
Category
  • Pain Management
  • Core Content
Format
  • Interactive Enduring Activity
Credits
  • 2.50 ABA MOC
  • 2.50 ABIM MOC
  • 2.50 ABP MOC
  • 2.50 ABS MOC
  • 2.50 CME (physician only)
  • 2.50 Participation